# Follicular helper-like γδ T cells promote plasma cell differentiation in Behçet’s disease

**Authors:** Sahar Shaaban Mohammed, Abdullah Khalifah S. Alkhalifah, Rahilah Mirza, Sarah-Pristine Omoefe Okinedo, Rani Aishwarya Inampudi, Azimoon Bibi, Amal Senusi, Claire Pardieu, Neil E. McCarthy, Farida Fortune, Fabian Flores-Borja

PMC · DOI: 10.3389/fimmu.2026.1763174 · Frontiers in Immunology · 2026-02-09

## TL;DR

This study shows that a specific type of T cell helps B cells produce antibodies in Behçet’s disease, which may contribute to the disease’s progression.

## Contribution

The study identifies a novel interaction between γδT cells and B cells that promotes plasma cell differentiation in Behçet’s disease.

## Key findings

- BD patients with active disease have increased CXCR5+PD-1+ Vδ2 T cells resembling follicular helper T cells.
- BD-derived Vδ2 T cells promote B cell proliferation and plasma cell differentiation in vitro.
- Cultures from BD patients show elevated cytokines and anti-HSP60 autoantibodies compared to healthy controls.

## Abstract

Behçet’s disease (BD) is a systemic vasculitis characterized by recurrent oral and genital ulcers. The disease can manifest diverse phenotypes -such as mucocutaneous, ocular BD- with an uncertain role for autoantibodies in disease pathogenesis. Altered γδT-cell and B-cell phenotypes have been widely reported in BD, but it remains unknown whether these lineages can interact to promote autoantibody production.

This study included 75 patients with a BD diagnosis, alongside 41 healthy control (HC) volunteers. We performed ex vivo flow-cytometric profiling of blood γδT and B cells, established a cell culture system to investigate plasma cell generation in vitro, and quantified anti-HSP60 autoantibody levels in BD and HC participants’ serum and cell culture supernatants.

BD patients with active disease displayed a significant increase in the frequency of cells CXCR5+PD-1+ Vδ2 T cells resembling a follicular helper-like functional state. Upon stimulation, Vδ2 T cells from BD patients showed increased expression of ICOS and CXCR5, induced significant B cell proliferation, and promoted differentiation of plasma cells in vitro. Cultures of cells from BD patients contained increased levels of multiple cytokines that can support plasma cell differentiation (IL-4, IL-10, IL-17, CXCL13, TNF-α, IFN-γ). Anti-HSP60 autoantibodies were significantly enriched in blood serum from BD patients with active disease as well as the supernatants of patient-derived cell cultures compared to the healthy volunteer cell cultures.

Our findings suggest that γδT cells may enhance B-cell differentiation into antibody-producing plasma cells in BD patients with mucocutaneous and ocular clinical phenotypes.

## Linked entities

- **Proteins:** HSPD1 (heat shock protein family D (Hsp60) member 1), CXCR5 (C-X-C motif chemokine receptor 5), PDCD1 (programmed cell death 1), ICOS (inducible T cell costimulator), IL4 (interleukin 4), IL10 (interleukin 10), IL17A (interleukin 17A), CXCL13 (C-X-C motif chemokine ligand 13), TNF (tumor necrosis factor), IFNG (interferon gamma)
- **Diseases:** Behçet’s disease (MONDO:0007191), vasculitis (MONDO:0018882)

## Full-text entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, PAX5 (paired box 5) [NCBI Gene 5079] {aka ALL3, BSAP, PAX-5}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CCR5 (C-C motif chemokine receptor 5) [NCBI Gene 1234] {aka CC-CKR-5, CCCKR5, CCR-5, CD195, CKR-5, CKR5}, CD79A (CD79a molecule) [NCBI Gene 973] {aka IGA, IGAlpha, MB-1, MB1}, HSPD1 (heat shock protein family D (Hsp60) member 1) [NCBI Gene 3329] {aka CPN60, GROEL, HLD4, HSP-60, HSP60, HSP65}, CXCL13 (C-X-C motif chemokine ligand 13) [NCBI Gene 10563] {aka ANGIE, ANGIE2, BCA-1, BCA1, BLC, BLR1L}, HLA-C (major histocompatibility complex, class I, C) [NCBI Gene 3107] {aka D6S204, HLA-JY3, HLAC, HLC-C, MHC, PSORS1}, PDCD1 (programmed cell death 1) [NCBI Gene 5133] {aka ADMIO4, AIMTBS, CD279, PD-1, PD1, SLEB2}, CTDP1 (CTD phosphatase subunit 1) [NCBI Gene 9150] {aka CCFDN, FCP1}, ICOS (inducible T cell costimulator) [NCBI Gene 29851] {aka AILIM, CD278, CVID1}, IL15 (interleukin 15) [NCBI Gene 3600] {aka IL-15}, IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}, CD27 (CD27 molecule) [NCBI Gene 939] {aka S152, S152. LPFS2, T14, TNFRSF7, Tp55}, CD19 (CD19 molecule) [NCBI Gene 930] {aka B4, CVID3}, CXCR5 (C-X-C motif chemokine receptor 5) [NCBI Gene 643] {aka BLR1, CD185, MDR15}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, IL21 (interleukin 21) [NCBI Gene 59067] {aka CVID11, IL-21, Za11}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, IRF4 (interferon regulatory factor 4) [NCBI Gene 3662] {aka IMD131, LSIRF, MUM1, NF-EM5, SHEP8}, HGF (hepatocyte growth factor) [NCBI Gene 3082] {aka DFNB39, F-TCF, HGFB, HPTA, SF}, PRDM1 (PR/SET domain 1) [NCBI Gene 639] {aka BLIMP-1, BLIMP1, PRDI-BF1}, CD40LG (CD40 ligand) [NCBI Gene 959] {aka CD154, CD40L, HIGM1, IGM, IMD3, T-BAM}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}
- **Diseases:** HC (MESH:D000067329), oral and genital ulcers (MESH:D019226), vasculitis (MESH:D014657), inflammation (MESH:D007249), infection (MESH:D007239), systemic vasculitis (MESH:D056647), uveitis (MESH:D014605), autoimmune (MESH:D001327), BD (MESH:D001528), SCID (MESH:D016511), tissue damage (MESH:D017695), SLE (MESH:D008180)
- **Chemicals:** ionomycin (MESH:D015759), penicillin (MESH:D010406), BioLegend (-), Monensin (MESH:D008985), streptomycin (MESH:D013307), EDTA (MESH:D004492), amino acids (MESH:D000596), PMA (MESH:D013755), nitrogen (MESH:D009584), PFA (MESH:C003043), HMB (MESH:C004961), L-glutamine (MESH:D005973), (E)-4-Hydroxy-3methyl-but-2-enyl pyrophosphate (MESH:C467061), HMB-PP (MESH:C443995), hyaluronic acid (MESH:D006820), CMFDA (MESH:C069306), dimethyl sulfoxide (MESH:D004121), IPP (MESH:C004809)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** HMB-PP — Mus musculus (Mouse), Hybridoma (CVCL_B5CX)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12926121/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12926121/full.md

## References

55 references — full list in the complete paper: https://tomesphere.com/paper/PMC12926121/full.md

---
Source: https://tomesphere.com/paper/PMC12926121